Displaying drugs 15126 - 15150 of 15214 in total
Ganglioside GM1
Investigational
Matched Iupac: … hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid …
CRA_1801
Experimental
ZK-806711
Experimental
Atpenin A5
Experimental
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
Metizoline
Experimental
CRA_10655
Experimental
GO-203-2C
GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Matched Iupac: … hydroxypentylidene]amino}-1-hydroxypentylidene]amino}-1-hydroxyhexylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoic acid …
CRA_9785
Experimental
CRA_10656
Experimental
Gantacurium
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Investigational
CRA-9334
Experimental
Displaying drugs 15126 - 15150 of 15214 in total